Patent Assignment
Reel/Frame 016835/0938
Certificate of Ownership and Merger
Recorded: 2005-09-29
Received: 2005-09-29
Pages: 14
Assignor
HYBRIDON INC.
Executed: 2005-09-12
Assignee
IDERA PHARMACEUTICALS, INC.
345 VASSAR STREET, (A DELAWARE CORPORATION), CAMBRIDGE, MA, 02139-4818, UNITED STATES
Covered Properties
(13)
Modified protein kinase a-specific oligonucleotides and methods of their use
Application:
10/854,989 →
Modified protein kinase A-specifc oligonucleotides and methods of their use
Application:
10/641,521 →
Method of down-regulating gene expression
Application:
10/640,898 →
Saddle Tank Fuel Delivery System
Application:
10/349,416 →
Mixed backbone oligonucleotides containing pops blocks to obtain reduced phosphorothioate content
Application:
10/291,058 →
Antisense oligonucleotides and methods to induce tumor cell death
Application:
10/253,132 →
Hyperstructure-forming carriers
Application:
10/265,590 →
Epidermal Growth Factor Receptor Antisense Oligonucleotides
Application:
10/140,228 →
Cooperative oligonucleotides
Application:
10/054,429 →
Novel Hiv-Specific Synthetic Oligonucleotides and Methods of Their Use
Application:
09/896,692 →
Modulation of Oligonucleotide Cpg-Mediated Immune Stimulation by Positional Modification of Nucleosides
Application:
09/845,623 →
Novel HIV-specific synthetic oligonucleotides and methods of their use
Application:
09/837,806 →
Method of Down-Regulating Gene Expression
Application:
09/777,526 →